Literature DB >> 18436079

Targeting proteinuria as a valid surrogate for individualized kidney protective therapy.

Dick de Zeeuw.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18436079     DOI： 10.1053/j.ajkd.2008.03.013

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  5 in total

1.  Relapse or worsening of nephrotic syndrome in idiopathic membranous nephropathy can occur even though the glomerular immune deposits have been eradicated.

Authors:  Chadwick E Barnes; William A Wilmer; Raul A Hernandez; Christopher Valentine; Leena S Hiremath; Tibor Nadasdy; Anjali A Satoskar; Rose L Shim; Brad H Rovin; Lee A Hebert
Journal:  Nephron Clin Pract       Date:  2011-07-08

Review 2.  Aldosterone: effects on the kidney and cardiovascular system.

Authors:  Marie Briet; Ernesto L Schiffrin
Journal:  Nat Rev Nephrol       Date:  2010-03-16       Impact factor: 28.314

3.  The effect of n-3 long-chain polyunsaturated fatty acid supplementation on urine protein excretion and kidney function: meta-analysis of clinical trials.

Authors:  Edgar R Miller; Stephen P Juraschek; Lawrence J Appel; Madhavi Madala; Cheryl A M Anderson; Joachim Bleys; Eliseo Guallar
Journal:  Am J Clin Nutr       Date:  2009-04-29       Impact factor: 7.045

4.  Targeting tubulointerstitial remodeling in proteinuric nephropathy in rats.

Authors:  Saleh Yazdani; Ryanne S Hijmans; Fariba Poosti; Wendy Dam; Gerjan Navis; Harry van Goor; Jacob van den Born
Journal:  Dis Model Mech       Date:  2015-05-14       Impact factor: 5.758

5.  11. Laboratory Standards in the Diagnosis and Monitoring of Therapy.

Authors:  Draško Pavlović
Journal:  EJIFCC       Date:  2009-04-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.